← Back to headlines
ImmunityBio Reaches New High on Anktiva Expansion Prospects
ImmunityBio (IBRX) stock soared to a new high, driven by optimism surrounding the future expansion of its drug Anktiva.
19 Feb, 11:08 — 19 Feb, 11:08
Sources
Showing 1 of 1 sources
